State Street
OLMA icon

State Street’s Olema Pharmaceuticals OLMA Stock Holding History

State Street’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54M Buy
4,316,058
+378,227
+10% +$5.07M ﹤0.01% 1795
2026
Q1 		$58.7M Buy
3,937,831
+2,053,432
+109% +$45.7M ﹤0.01% 1656
2025
Q4 		$47.1M Buy
1,884,399
+790,825
+72% +$14.1M ﹤0.01% 1772
2025
Q3 		$10.7M Buy
1,093,574
+41,607
+4% +$250K ﹤0.01% 2600
2025
Q2 		$4.48M Buy
1,051,967
+186,411
+22% +$831K ﹤0.01% 2991
2025
Q1 		$3.25M Sell
865,556
-991,971
-53% -$4.99M ﹤0.01% 3054
2024
Q4 		$10.8M Sell
1,857,527
-112,436
-6% -$1.12M ﹤0.01% 2589
2024
Q3 		$23.5M Buy
1,969,963
+21,986
+1% +$281K ﹤0.01% 2112
2024
Q2 		$21.1M Sell
1,947,977
-1,230,450
-39% -$13.3M ﹤0.01% 2143
2024
Q1 		$36M Buy
3,178,427
+2,505,257
+372% +$32.3M ﹤0.01% 1895
2023
Q4 		$9.44M Buy
673,170
+114,053
+20% +$1.53M ﹤0.01% 2630
2023
Q3 		$6.91M Buy
559,117
+63,417
+13% +$646K ﹤0.01% 2767
2023
Q2 		$4.48M Buy
495,700
+374,519
+309% +$2.26M ﹤0.01% 3041
2023
Q1 		$420K Buy
121,181
+12,100
+11% +$49.4K ﹤0.01% 3801
2022
Q4 		$267K Buy
109,081
+8,600
+9% +$25.1K ﹤0.01% 3991
2022
Q3 		$277K Hold
100,481
– – ﹤0.01% 3997
2022
Q2 		$409K Sell
100,481
-359,072
-78% -$1.14M ﹤0.01% 3913
2022
Q1 		$1.96M Buy
459,553
+39,522
+9% +$218K ﹤0.01% 3576
2021
Q4 		$3.93M Buy
420,031
+34,201
+9% +$709K ﹤0.01% 3353
2021
Q3 		$10.6M Buy
385,830
+181,474
+89% +$4.9M ﹤0.01% 2858
2021
Q2 		$5.72M Buy
204,356
+30,510
+18% +$868K ﹤0.01% 3184
2021
Q1 		$5.77M Buy
+173,846
New +$7.45M ﹤0.01% 2988

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street's OLMA Position: Q2 2026 in Review

State Street increased its Olema Pharmaceuticals (OLMA) stake by 9.6% in Q2 2026, buying an estimated $5.07M and bringing the position to 4,316,058 shares worth $54M. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

State Street first reported a position in OLMA in Q1 2021 and has held it in 22 quarters since. The position peaked at $58.7M in Q1 2026. 43 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • State Street held 4,316,058 shares of Olema Pharmaceuticals worth $54M as of Q2 2026.
  • State Street bought 378,227 Olema Pharmaceuticals shares in Q2 2026, an estimated $5.07M.
  • Olema Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1795 holding.
  • State Street first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • State Street's Olema Pharmaceuticals position peaked at $58.7M in Q1 2026.
  • 43 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.